Citius Pharmaceuticals (CTXR) Invested Capital (2014 - 2017)
Citius Pharmaceuticals' (CTXR) quarterly Invested Capital came in at $17637.0 in Q4 2017, down 36.18% YoY from $27637.0 in Q4 2016, and down 36.18% on a QoQ basis from $27637.0 in Q3 2017.
Citius Pharmaceuticals (CTXR) Invested Capital (2014 - 2017) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 4 years of Invested Capital data on file, last reported at $17637.0 in Q4 2017.
- Quarterly Invested Capital fell 36.18% year-over-year to $17637.0 in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $17637.0 (down 84.05% YoY) and the FY2017 annual result came in at $27637.0, changed 0.0% from the prior year.
- Invested Capital fell to $17637.0 in Q4 2017, from $27637.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $86942.0 in Q1 2015 to a low of $17637.0 in Q4 2017.
- A 4-year average of $46040.4 and a median of $37637.0 in 2016 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2015 — Invested Capital climbed 25.39% — and 2016, when it slumped 60.74%.
- Tracing CTXR's Invested Capital over 4 years: stood at $56134.0 in 2014, then rose by 25.39% to $70386.0 in 2015, then tumbled by 60.74% to $27637.0 in 2016, then sank by 36.18% to $17637.0 in 2017.
- The last three Invested Capital figures came in at $17637.0 (Q4 2017), $27637.0 (Q3 2017), and $27637.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 17,637.00 |
| Sep 30, 2017 | 27,637.00 |
| Jun 30, 2017 | 27,637.00 |
| Mar 31, 2017 | 27,637.00 |
| Dec 31, 2016 | 27,637.00 |
| Sep 30, 2016 | 27,637.00 |
| Jun 30, 2016 | 37,637.00 |
| Dec 31, 2015 | 70,386.00 |
| Sep 30, 2015 | 70,386.00 |
| Jun 30, 2015 | 65,084.00 |
| Mar 31, 2015 | 86,942.00 |
| Dec 31, 2014 | 56,134.00 |
| Sep 30, 2014 | 56,134.00 |